Raymond James & Associates’s Ampio Pharmaceuticals Inc. AMPE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-238
| Closed | -$4K | – | 3964 |
|
|
2022
Q3 | $4K | Buy |
238
+17
| +8% | +$286 | ﹤0.01% | 3780 |
|
|
2022
Q2 | $11K | Sell |
221
-3
| -1% | -$149 | ﹤0.01% | 3825 |
|
|
2022
Q1 | $32K | Hold |
224
| – | – | ﹤0.01% | 3860 |
|
|
2021
Q4 | $38K | Sell |
224
-492
| -69% | -$83.5K | ﹤0.01% | 3896 |
|
|
2021
Q3 | $357K | Sell |
716
-4
| -0.6% | -$1.99K | ﹤0.01% | 3277 |
|
|
2021
Q2 | $361K | Buy |
720
+79
| +12% | +$39.6K | ﹤0.01% | 3294 |
|
|
2021
Q1 | $325K | Sell |
641
-2
| -0.3% | -$1.01K | ﹤0.01% | 3281 |
|
|
2020
Q4 | $307K | Buy |
643
+5
| +0.8% | +$2.39K | ﹤0.01% | 3089 |
|
|
2020
Q3 | $183K | Sell |
638
-10
| -2% | -$2.87K | ﹤0.01% | 3221 |
|
|
2020
Q2 | $124K | Sell |
648
-17
| -3% | -$3.25K | ﹤0.01% | 3217 |
|
|
2020
Q1 | $83K | Buy |
665
+3
| +0.5% | +$374 | ﹤0.01% | 3220 |
|
|
2019
Q4 | $116K | Buy |
662
+25
| +4% | +$4.38K | ﹤0.01% | 3412 |
|
|
2019
Q3 | $96K | Buy |
637
+167
| +36% | +$25.2K | ﹤0.01% | 3359 |
|
|
2019
Q2 | $55K | Buy |
470
+50
| +12% | +$5.85K | ﹤0.01% | 3436 |
|
|
2019
Q1 | $71K | Buy |
420
+367
| +692% | +$62K | ﹤0.01% | 3400 |
|
|
2018
Q4 | $6K | Sell |
53
-208
| -80% | -$23.5K | ﹤0.01% | 3418 |
|
|
2018
Q3 | $40K | Buy |
261
+56
| +27% | +$8.58K | ﹤0.01% | 3447 |
|
|
2018
Q2 | $135K | Buy |
205
+8
| +4% | +$5.27K | ﹤0.01% | 3323 |
|
|
2018
Q1 | $201K | Buy |
197
+85
| +76% | +$86.7K | ﹤0.01% | 3112 |
|
|
2017
Q4 | $137K | Buy |
+112
| New | +$137K | ﹤0.01% | 3127 |
|
|
2017
Q3 | – | Sell |
-53
| Closed | -$8K | – | 3343 |
|
|
2017
Q2 | $8K | Hold |
53
| – | – | ﹤0.01% | 3170 |
|
|
2017
Q1 | $13K | Sell |
53
-2
| -4% | -$491 | ﹤0.01% | 3114 |
|
|
2016
Q4 | $15K | Buy |
55
+14
| +34% | +$3.82K | ﹤0.01% | 3064 |
|
|
2016
Q3 | $9K | Buy |
+41
| New | +$9K | ﹤0.01% | 3057 |
|